- Home
- BRNS vs ICMB Comparison
BRNS vs ICMB Comparison
Compare BRNS & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- ICMB
- Stock Information
- Founded
- BRNS 2016
- ICMB 2012
- Country
- BRNS United Kingdom
- ICMB United States
- Employees
- BRNS N/A
- ICMB N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- BRNS Health Care
- ICMB Finance
- Exchange
- BRNS Nasdaq
- ICMB Nasdaq
- Market Cap
- BRNS 41.0M
- ICMB 46.5M
- IPO Year
- BRNS 2021
- ICMB N/A
- Fundamental
- Price
- BRNS $1.09
- ICMB $3.02
- Analyst Decision
- BRNS Strong Buy
- ICMB
- Analyst Count
- BRNS 2
- ICMB 0
- Target Price
- BRNS $4.00
- ICMB N/A
- AVG Volume (30 Days)
- BRNS 42.0K
- ICMB 37.0K
- Earning Date
- BRNS 11-06-2024
- ICMB 02-10-2025
- Dividend Yield
- BRNS N/A
- ICMB 15.74%
- EPS Growth
- BRNS N/A
- ICMB N/A
- EPS
- BRNS N/A
- ICMB 0.29
- Revenue
- BRNS $14,969,000.00
- ICMB $24,827,371.00
- Revenue This Year
- BRNS $1,805.74
- ICMB N/A
- Revenue Next Year
- BRNS N/A
- ICMB N/A
- P/E Ratio
- BRNS N/A
- ICMB $10.46
- Revenue Growth
- BRNS 106.21
- ICMB N/A
- 52 Week Low
- BRNS $0.80
- ICMB $2.91
- 52 Week High
- BRNS $4.16
- ICMB $3.96
- Technical
- Relative Strength Index (RSI)
- BRNS 50.24
- ICMB 35.92
- Support Level
- BRNS $0.98
- ICMB $3.02
- Resistance Level
- BRNS $1.20
- ICMB $3.24
- Average True Range (ATR)
- BRNS 0.14
- ICMB 0.09
- MACD
- BRNS 0.02
- ICMB -0.02
- Stochastic Oscillator
- BRNS 55.46
- ICMB 0.00
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.